A major subgroup of Beijing family Mycobacterium tuberculosis is associated with multidrug resistance and increased transmissibility

Epidemiology and Infection

Volumn 139, Issue 1, 2011, Pages 130-138

  Hu, Y ^a   Ma, X ^b   Graviss, E A ^b   Wang, W ^a   Jiang, W ^a   Xu, B ^a  

^a FUDAN UNIVERSITY   (China)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Beijing family; IS6110 restriction fragment length polymorphism; mycobacterial interspersed repetitive units; Mycobacterium tuberculosis; spoligotyping

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; BACTERIAL PROTEIN; CATALASE; KATG PROTEIN, MYCOBACTERIUM TUBERCULOSIS; RPOB PROTEIN, MYCOBACTERIUM TUBERCULOSIS;

ADULT; AGED; ARTICLE; BACTERIAL MUTATION; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MUTATION RATE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RURAL AREA; ADOLESCENT; CLASSIFICATION; CLUSTER ANALYSIS; DISEASE TRANSMISSION; DRUG EFFECT; GENETICS; MICROBIOLOGY; MIDDLE AGED; MUTATION; RISK; STATISTICAL MODEL; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; CATALASE; CHINA; CLUSTER ANALYSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUTATION; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; TUBERCULOSIS; YOUNG ADULT;

EID: 79952118228     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810000890     Document Type: Article

References (30)

1. WHO. Global tuberculosis control : surveilance, planning, financing. WHO report, 2008. Geneva: World Health Organization, 2008, pp. 10.
2. Wang L, Liu J, Chin DP. Progress in tuberculosis control and the evolving public-health system in China. Lancet 2007; 369: 691-696.
3. Wang S, Zhang F, Duanmu H. Study on epidemic of drug-resistant tuberculosis in Shandong province, China. Zhonghua Jie He He Hu Xi Za Zhi 1999; 22: 728-730.
4. WHO. Global Project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the world, 4th Global Report, 2007. Geneva: World Health Organization, 2007, pp. 11.
5. Chinese Ministry of Health. Reports on nationalwide random survey for the epidemiology of tuberculosis in 2002. Zhongguo Fang Lao Za zhi 2002; 24: 65-107.
6. Liu Y, et al. Drug resistance of Mycobacterium tuberculosis in a nationwide epidemiological survey in China in the year of 2000. Zhonghua Jie He He Hu Xi Za Zhi 2002; 25: 224-227.
7. Zignol M, et al. Global incidence of multidrug-resistant tuberculosis. Journal of Infectious Diseases 2006; 194: 479-485. (Pubitemid 44162659)
8. Liu JJ, et al. Analysis on the relationship between tuberculosis case detection and short-course coverage of directly observed treatment in China. Zhonghua Liu Xing Bing Xue Za Zhi 2004; 25: 647-649.
9. van Soolingen D, et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. Journal of Clinical Microbiology 1995; 33: 3234-3238.
10. Li WM, et al. Molecular epidemical characteristics of Mycobacterium tuberculosis strains from the nationwide random survey for the epidemiology of tuberculosis in China, 2000. Zhonghua Yi Xue Za Zhi 2003; 83: 1210-1213.
11. Hu Y, et al. The combined application of multiple genotyping methods in identifying genotypes of Mycobacterium tuberculosis strain circulating in rural China. Zhonghua Jie He He Hu Xi Za Zhi 2009; 32: 576-580.
12. Park YK, et al. Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. Journal of Microbiological Methods 2005; 63: 165-72. (Pubitemid 41444246)
13. Toungoussova OS, et al. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family. Clinical Infectious Diseases 2003; 37: 665-672. (Pubitemid 37100807)
14. Glynn JR, et al. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis : A systematic review. Emerging Infectious Diseases 2002; 8: 843-849.
15. Ma X, et al. rpoB Gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. Journal of Clinical Microbiology 2006; 44: 3409-3412. (Pubitemid 44413791)
16. van Embden JD, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: Recommendations for a standardized methodology. Journal of Clinical Microbiology 1993; 31: 406-409. (Pubitemid 23028649)
17. Cowan LS, et al. Variable-number tandem repeat typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110 by using mycobacterial interspersed repetitive units. Journal of Clinical Microbiology 2002; 40: 1592-1602. (Pubitemid 34493125)
18. Selander RK, et al. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Applied and Environmental Microbiology 1986; 51: 873-884. (Pubitemid 16078577)
19. Hunter PR, Gaston MA. Numerical index of the discriminatory ability of typing systems : An application of Simpson's index of diversity. Journal of Clinical Microbiology 1988; 26: 2465-2466.
20. Hu Y, et al. Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China. Microbial Drug Resistance 2008; 14: 227-232.
21. Xu B, et al. DOTS in China - removing barriers or moving barriers ? Health Policy Plan 2006; 21: 365-372. (Pubitemid 44594423)
22. Xu B, et al. Diagnostic delays in access to tuberculosis care in counties with or without the National Tuberculosis Control Programme in rural China. International Journal of Tuberculosis and Lung Disease 2005; 9: 784-790. (Pubitemid 41139132)
23. Theus S, et al. Beijing family Mycobacterium tuberculosis strains differ in their intracellular growth in THP-1 macrophages. International Journal of Tuberculosis and Lung Disease 2007; 11: 1087-1093. (Pubitemid 47605398)
24. Fang Z, et al. IS6110-mediated deletions of wildtype chromosomes of Mycobacterium tuberculosis. J Bacteriol 1999; 181: 1014-1020. (Pubitemid 29061587)
25. Beggs ML, Eisenach KD, Cave MD. Mapping of IS6110 insertion sites in two epidemic strains of Mycobacterium tuberculosis. Journal of Clinical Microbiology 2000; 38: 2923-2928. (Pubitemid 30640575)
26. Safi H, et al. IS6110 functions as a mobile, monocyteactivated promoter in Mycobacterium tuberculosis. Molecular Microbiology 2004; 52: 999-1012. (Pubitemid 38922821)
27. Andersson DI. The biological cost of mutational antibiotic resistance : Any practical conclusions ? Current Opinion in Microbiology 2006; 9: 461-465. (Pubitemid 44397630)
28. Rouse DA, et al. Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis : Effects on catalase- peroxidase activities and isoniazid resistance. Molecular Microbiology 1996; 22: 583-592. (Pubitemid 26373841)
29. Kapetanaki SM, et al. Mycobacterium tuberculosis KatG(S315T) catalase-peroxidase retains all active site properties for proper catalytic function. Biochemistry 2005; 44: 243-252. (Pubitemid 40100545)
30. van Soolingen D, et al. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. Journal of Infectious Diseases 2000; 182: 1788-1790.